Type 2 (T2) inflammation represents the predominant immunological pathway in asthma and is characterized by eosinophilic airway infiltration together with Th2-dependent overproduction of cytokines such as IL-4, IL-5, and IL-13. This evidence concerns the gene IL13 and asthma.